Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Plymouth Meeting, PA
SEC filing record 1 source field available
Fiscal year end
31 December
INOVIO PHARMACEUTICALS, INC. has filed 1,289 SEC EDGAR filings since 29 Jun 1999

SEC filing history

Showing 776-800 of 873 matching filings.

Per page
25
Current page
32
4

FORM 4 -

Filing date
27 Feb 2012
Reporting date
23 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
27 Feb 2012
Reporting date
23 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
27 Feb 2012
Reporting date
23 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
27 Feb 2012
Reporting date
23 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-14888

CT ORDER filing

Filing date
27 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60487

INOVIO PHARMACEUTICALS 13G/A

Filing date
13 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
11 Jan 2012
Reporting date
03 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14888

FORM 8-K

Filing date
06 Jan 2012
Reporting date
03 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Jan 2012
Reporting date
03 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
04 Jan 2012
Reporting date
03 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Dec 2011
Reporting date
13 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Dec 2011
Reporting date
09 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Dec 2011
Reporting date
07 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Dec 2011
Reporting date
05 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14888

FORM 8-K

Filing date
07 Dec 2011
Reporting date
06 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Dec 2011
Reporting date
01 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-176670

PROSPECTUS SUPPLEMENT

Filing date
01 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14888

FORM 8-K

Filing date
01 Dec 2011
Reporting date
01 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-176670

PROSPECTUS SUPPLEMENT - INOVIO PHARMACEUTICALS

Filing date
30 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-14888

AMENDMENT TO FORM 8-K - INOVIO PHARMACEUTICALS, INC.

Filing date
26 Oct 2011
Reporting date
07 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Oct 2011
Reporting date
17 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Oct 2011
Reporting date
11 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Oct 2011
Reporting date
06 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14888

FORM 8-K

Filing date
11 Oct 2011
Reporting date
07 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .